IL-4 and IL-13 type I and II receptor signaling pathways are linked to Signal Transducer and Activator of Transcription 6 (STAT6) expression (39), responsible for mediating IL-4 and IL-13 immune signaling, increase proliferation, adhesion and viability of endometriosis lesions (38). The gene discussed is IL4; the disease is endometriosis.